Department of Neurosurgery, Faculty of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey.
Department of Pharmacology, Faculty of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey.
Neurol Res. 2021 Dec;43(12):1107-1115. doi: 10.1080/01616412.2021.1949689. Epub 2021 Aug 31.
To investigate the histopathological effects of a peripheral benzodiazepine receptor agonist (Ro5-4864) on epidural fibrosis (EF) in an experimental study model (post-laminectomy) in rats.
A total of 32 albino Wistar rats were randomly divided into four equal groups (n = 8). In Group 1, no treatment was applied after laminectomy (control group). In Group 2, hemostasis was achieved after Laminectomy, and the surgical procedure was terminated by placing a 2-mm absorbable gelatin sponge dipped in saline into the epidural space. In Group 3, low-dose (4 mg/kg) Ro5-4864 was administered 30 minutes before the surgery. In Group 4, high-dose (8 mg/kg) Ro5-4864 was administered 30 minutes before the surgery. A histopathological examination was performed to evaluate arachnoidal invasion and EF.
Our data revealed the EF was significantly reduced in rats treated with high-dose Ro5-4864 (Group 4) compared to the control and saline-soaked Spongostan groups (p = 0.000 and p = 0.006, respectively). There was no significant difference between the groups treated with high- and low-dose Ro5-4864. Arachnoidal invasion was not seen in any of the rats in the high-dose R05-4864 group. However, the arachnoidal invasion results did not significantly differ between the study groups (p = 0.052 = 0.05).
Our study showed that Ro5-4864 could be effective in reducing EF in rats after.
在大鼠实验模型(椎板切除术后)中研究外周苯二氮䓬受体激动剂(Ro5-4864)对硬膜外纤维化(EF)的组织病理学影响。
共 32 只白化 Wistar 大鼠随机分为四组(n = 8)。在第 1 组中,椎板切除术后不进行任何治疗(对照组)。在第 2 组中,在椎板切除术后进行止血,并通过将浸泡在生理盐水中的 2mm 可吸收明胶海绵放入硬膜外腔来终止手术。在第 3 组中,Ro5-4864 在手术前 30 分钟给予低剂量(4mg/kg)。在第 4 组中,Ro5-4864 在手术前 30 分钟给予高剂量(8mg/kg)。进行组织病理学检查以评估蛛网膜侵犯和 EF。
我们的数据显示,与对照组和生理盐水浸泡的 Spongostan 组相比,高剂量 Ro5-4864 治疗的大鼠 EF 显著减少(p=0.000 和 p=0.006)。高剂量和低剂量 Ro5-4864 治疗组之间没有显著差异。高剂量 R05-4864 组的任何大鼠均未出现蛛网膜侵犯。然而,各组之间的蛛网膜侵犯结果无显著差异(p=0.052)。
我们的研究表明,Ro5-4864 可有效减少大鼠椎板切除术后 EF。